Skip to main content
Review Article
Review of PD-1–Induced Myositis and a Case of Pembrolizumab-Induced Myositis in a Patient with Metastatic Melanoma
Kirollos S. Hanna, PharmD, BCPS, BCOP
Kirollos S. Hanna, PharmD, BCPS, BCOP
Read More
Symptom Management Overview
Anthracycline-Induced Cardiotoxicity in Adults
Linda Blake, PharmD, PhD, BCPS, Alison Palumbo, PharmD, MPH, BCOP, Amber Diaz, PharmD, BCOP, Joseph Bubalo, PharmD, BCPS, BCOP
Linda Blake, PharmD, PhD, BCPS; Alison Palumbo, PharmD, MPH, BCOP; Amber Diaz, PharmD, BCOP; and Joseph Bubalo, PharmD, BCPS, BCOP
Read More
Colorectal Cancer, Immunotherapy
Nivolumab-Ipilimumab Combination Highly Active in Metastatic MSI-H or dMMR Colorectal Cancer
Read More
Targeted Intervention Reduces Opioid Use by Nearly 50% After Urologic Oncology Surgery
Read More
Supportive Care
Managing Bone Metastases Through a Multidisciplinary Approach
Meg Barbor, MPH
Read More
FDA Updates
Braftovi Plus Mektovi a New Combination for Unresectable or Metastatic Melanoma with BRAF Mutation
Read More
Cannabis for Symptom Management in Cancer: Do You Know What Your Patients Are Using?
Read More
Immunotherapy
Building on the Successes of Cancer Immunotherapy
Charles Bankhead
Read More
Drug Resistance
Oral Toxicities Associated with Cancer Therapies: What’s Old Is New Again
Meg Barbor, MPH
Read More
TLR9 Agonist plus Immunotherapy May Overcome Resistance to PD-1 Inhibition
Phoebe Starr
Read More
Page 157 of 199
Results 1561 - 1570 of 1986